{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.390","meta":{"versionId":"4","lastUpdated":"2023-04-03T14:03:52.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.390","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.390"}],"version":"20171201","name":"GnRHPrescribedOrAdministered","title":"GnRH prescribed or administered","status":"active","experimental":false,"date":"2017-12-01T01:00:04-05:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"4164F","display":"Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)"}]}]},"expansion":{"identifier":"urn:uuid:7561d581-a590-4c0d-99d8-d4faf181e389","timestamp":"2023-12-10T21:39:27-05:00","total":1,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"4164F","display":"Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)"}]}}